We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Clearstream | LSE:CTN | London | Ordinary Share | IE00B03QHM52 | ORD EUR0.125 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 84.50 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
01/6/2011 14:48 | well done, a keen price. | spaceparallax | |
01/6/2011 10:46 | The 6000 @ 47.75p was my BUY, not a sell. Got in below placing price. | philo124 | |
13/5/2011 15:31 | There seems to be a modest response to the share rec. | spaceparallax | |
13/5/2011 13:23 | Hectorp, thanks for that and for once in a long while, will go and grab a copy. As for CTN, i must say i have been surprised by the volatility over the last few months and to be honest, having bought in at 23p last Autumn didn't expect such a ride. Really thought that this would be one to move forward gradually, as opposed to the way it has gone. I had the stock put forward to me from a friend here in Cambridge, who knew quite a bit about the Company and where they were heading. I note that you are not convinced of the story here and that is fair enough, but i continue to hold and feel that this is a decent long term play with solid potential. Institutions already had a large presence prior to the recent placing and while there was clearly an element of seizing the moment, it was good to see that it was oversubscribed. | hastings | |
13/5/2011 11:34 | Cheers H, I don't take any mags atm. The PEG here is certainly attractive in combination with the PER. Are you into fine wine? | spaceparallax | |
13/5/2011 11:29 | Tipped in the Shares rag, space.. but forecast EPS will be higher in 2012 not so much so in 2011. Very low PEG of 0.22, less than 1 is decent, so should be a secure enough share to hold. I'm not yet convinced. A good volatile trading range recently, for traders, but again, thats not really me. (off topic they also tipped as very low P/E low peg stocks, loads of them, dozens, but you need to get the magazine for that info. For a chage, it is looking worth the £3.95p.) H. | hectorp | |
12/5/2011 09:57 | Interesting to see that the selling's almost dried up with people seeing 50p as support and the keenest price they're likely to get. | spaceparallax | |
10/5/2011 12:42 | Yes, it a bit of news now wouldn't go amiss. Having said that,any further retraction gives another opportunity to add. | hastings | |
10/5/2011 09:02 | we could do with a little news here | spaceparallax | |
05/5/2011 13:11 | Are you aware of GTL - might be worth a look particularly the recent posts by caveat emptor - highlights a great diversification stream for an already strong business. | spaceparallax | |
05/5/2011 13:10 | ironically, I had thought the selling dried up - I'm thinking of grabbing another 10K if I can get them C50p | spaceparallax | |
05/5/2011 12:59 | Bit of a dip today on small volume. Should be interesting to see if Institutions add again over the next few months. | hastings | |
21/4/2011 14:10 | Modest but very evenly split trading over recent days - the share price is looking very durable, having shown so little of the retracement seen after previous sharp rises. | spaceparallax | |
18/4/2011 09:24 | A nice flurry of little buys this morning, can't be long before we tick-up towards the 60p level. | spaceparallax | |
14/4/2011 15:36 | Cheers 2B - that won't harm us. | spaceparallax | |
14/4/2011 15:22 | from the Cambridge news - Having delivered its interim results, Clearstream Technologies has now secured £2m via an oversubscribed placing with institutions at 48p. The shares responded positively, closing last week at 58.5p, and are well ahead of the 23p of last September when I first took a look. However, the market cap remains low, growth prospects strong and the shares look set to travel further northwards | 2breakout | |
13/4/2011 12:54 | L&G appear to have picked up a further 1.8M shares to take their stake up to 15.6%. That is as you say S, a real vote of confidence. | hastings | |
13/4/2011 12:40 | Yes, Very good to see. Institutions had been adding prior to the placing and i suspect that some of those sitting under the 3% will add further. | hastings | |
13/4/2011 10:55 | A nice vote of confidence from L&G We're reaching a situation where a large majority are in strong hands - with that will come a further reduction in liquidity and greater upward volatility in share price as news arrives. | spaceparallax | |
11/4/2011 12:53 | Agreed, we know that everything is in place to meet demand which looks set to really take off over the next few years. Wouldn't surprise me either if CTN didn't attract the attention of a larger suitor. | hastings | |
11/4/2011 12:47 | If things go according to Company expectations, we could easily be over £1pps | spaceparallax | |
11/4/2011 12:43 | Agree on both counts S. Not bothered about a few sells, nothing goes up in a complete straight line and feel that this time next year we should be nearer £1.00 than 50p! | hastings | |
11/4/2011 12:09 | I'll be very surprised if today's minor retracement lasts - the recent placing price should be more than enough to carry us well past the previous 57p high. Demand is likely to far outstrip the impact of the modest PTing. | spaceparallax | |
11/4/2011 10:29 | Cheers H. What a gorgeous w/e we've just had - our British weather seems to become less and less predictable. | spaceparallax | |
09/4/2011 17:34 | Shares comment Clear Stream Technologies, a medical devices company, is a BUY for Shares. The last fortnight's 15% drop in its share price from mid-March's 57p peak offers an excellent opportunity for investors. Clear Stream 's main engine for growth is the peripheral angioplasty market, which is a relatively new and rapidly growing surgical procedure. It accounted for 72% of all sales in the first half of its financial year. The US market for this kind of product is estimated to be $2.8 billion and is forecast to double by 2016. The £22.1m cap of Clear Stream has already partnered with two major US distributors, Cordis and C.R.Bard. So massive growth on the agenda, with capacity to meet demands in place. Best observation is that the mkt cap remains tiny compared to peers. If all continues to plan then a valuation of nearer £40M would look closer to the mark. | hastings |
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions